Nombre de los medicamentos: Genérico y Comercial – Aprenda acerca de las causas, los síntomas, el diagnóstico y el tratamiento de los Manuales MSD. Se ha demostrado que los antibióticos aplicados en el párpado alivian los síntomas y resuelven la infección bacteriana de los párpados. Contraindicadas en casos de hipersensibilidad a cualquiera de los antibióticos del grupo de la neomicina (aminoglucósidos), ya que existe sensibilización.
|Published (Last):||21 March 2010|
|PDF File Size:||4.41 Mb|
|ePub File Size:||8.14 Mb|
|Price:||Free* [*Free Regsitration Required]|
Trials with results Trials without results Clear advanced search filters. Similarly, most of the anophthalmic cavities are atypical in adults with loss of eyeball from traumatism. The trial involves single site in the Member State concerned. Review by the Competent Authority or Ethics Committee in the country concerned.
IMP with orphan designation in the indication. Bacterial eradication status defined as absence of all bacterial species present at or above pathological threshold at baseline in the study eye at Visit 3 Day 5 between SHP and placebo.
Full list of Inclusion criteria can be found in the protocol. Modified clinical resolution status, defined as a global clinical score of 0 or 1, at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 7.
Expanded clinical resolution status, defined as a global clinical score of 0, 1, or 2 with neither injection nor discharge having a score of 2, at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 8. Time to clinical resolution based upon assessments at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 9.
Key Secondary Efficacy Endpoints: Have a history of recurrent corneal erosion syndrome, either idiopathic or secondary to previous corneal trauma or dry eye syndrome; presence of corneal epithelial defect or any significant corneal opacity at Visit 1. Bacterial eradication status defined as absence of all bacterial species present at or above pathological threshold at baseline as assessed by bacterial culture at Visits 2 Day 34 Day 8and 5 Day 12 in the study eye 4. The primary objective of this study is to evaluate the efficacy of SHP based on clinical resolution defined as absence of bulbar conjunctival injection and ocular conjunctival discharge compared with placebo in the treatment of subjects with bacterial conjunctivitis in the study eye at Visit 3 Day 5.
Title of the trial for lay people, in easily understood, i. EU Clinical Trials Register.
Clinical Trials Register
Subjects of any age at Visit 1 Note: Have active or a history of ocular herpes. Absolute and change from baseline of the individual clinical signs bulbar conjunctival injection and ocular conjunctival discharge at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 5. The majority of patients positively responded to treatment.
Presence of nasolacrimal duct obstruction at Visit 1 Day 1. Clear advanced search filters. Date on which this record was first entered in the EudraCT database:. Allergic conjunctivitis and conjunctival retraction are the most frequent illnesses in the patients wearing ocular prosthesis for more than one year, due to Staphylococcus aureus presence resulting from frequent hygienic handling of the prosthesis.
Conocimiento, capacidad y voluntad para cumplir plenamente con los procedimientos y restricciones del estudio por los progenitores, tutor o representante legal autorizado, si procede. Have presence of any intraocular, corneal, or conjunctival ocular inflammation eg, uveitis, iritis, ulcerative keratitis, chronic blepharoconjunctivitisother than bacterial conjunctivitis.
The key secondary objective of this study is to evaluate the efficacy of SHP based on bacterial eradication defined as absence of all bacterial species present at or above pathological threshold at baseline compared with placebo in the treatment of subjects antibiotkcos bacterial conjunctivitis in the study eye at Visit 3 Day 5.
Clinical resolution status of bacterial conjunctivitis at Visits 2 Day 34 Day 8and 5 Day 12 in the study eye 3. For these items you should use the filters and not add them to your search terms in the text field. Arch Soc Esp Oftalmol.
Gotas para los ojos: ¿cuáles son más adecuadas para usted?
Trials with results Trials without results. Combination product that includes a device, but does not involve an Advanced Therapy.
Pneumonia AND sponsor name. Have a clinical diagnosis of suspected bacterial conjunctivitis in at least 1 eye confirmed by the presence of the following minimal clinical signs and symptoms in that same eye: Visit 3 Day 5 2. Uso de medicamentos de rescate. Neonates or infants ie. Committee on Advanced therapies CAT has issued a classification for this product.
Full list of Exclusion criteria can be found in the protocol. Questionnaire of the psychosocial profile of the patient with anophthalmia with indication of ocular prosthesis. Clinical trials The European Union Clinical Trials Register allows you to search for protocol and results information on: Have any known clinically significant optic nerve defects. Le siguen, en orden de frecuencia, las infecciones y el glaucoma. Tener un herpes ocular activo o antecedente.
Presence of significant, active condition in the posterior segment that requires invasive treatment eg, intravitreal treatment with vascular endothelial growth factor inhibitors or corticosteroids and may progress during the study participation period. How to search [pdf]. Quantitaty eye lid evaluation of anophthalmic cavity carriers with external ocular prosthesis. Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial.
Cancer AND drug name.
Sujetos de cualquier edad en la visita 1 Nota: Presence of any significant ophthalmic condition eg, Retinopathy of Prematurity, congenital cataract, congenital glaucoma or other congenital disorder with ophthalmic involvement that could affect study variables. The global clinical score defined as the sum of bulbar conjunctival injection and ocular conjunctival discharge and change from baseline in the global clinical score at Visits 2 Day 33 Day 54 Day 8and 5 Day 12 in the study eye 6.
Current or relevant history of physical or psychiatric ofyalmicos, any medical disorder that may make the subject unlikely to fully complete the study, or any condition that presents antibiotocos risk from the investigational product or procedures.